Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, Single-arm Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Administered by Epidural Injection in Subjects With Lumbosacral Radiculopathy

Trial Profile

An Open-label, Single-arm Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Administered by Epidural Injection in Subjects With Lumbosacral Radiculopathy

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Sciatica
  • Focus Pharmacodynamics; Registrational
  • Sponsors Scilex Holding; Semnur Pharmaceuticals
  • Most Recent Events

    • 26 Mar 2019 According to a Sorrento Therapeutics Media Release,Dr. Richard Radnovich is the principal investigator of this study.
    • 26 Mar 2019 According to a Sorrento Therapeutics Media Release, this study was conducted as a part of the FDA requirements for NDA submission, to characterize repeat dose pharmacodynamics (PD) with respect to hypothalamic-pituitary-adrenal (HPA) suppression using plasma cortisol levels, white blood cell count (WBC), and blood glucose levels.
    • 26 Mar 2019 Results published in the Sorrento Therapeutics Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top